0 NASDAQ Companies - February 28, 2024Inari Medical Reports Fourth Quarter 2023 Financial ResultsIRVINE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a […]Read More
0 NASDAQ Companies - February 28, 2024Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001ProBOSTON and ATLANTA, Feb. 28, 2024 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical […]Read More
0 NASDAQ Companies - February 28, 2024Alkami Announces Fourth Quarter 2023 Financial ResultsPLANO, Texas, Feb. 28, 2024 (GLOBE NEWSWIRE) — Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions […]Read More
0 NASDAQ Companies - February 28, 2024Lightbridge Provides Business Update and Announces Fiscal Year 2023 Financial ResultsRESTON, Va,, Feb. 28, 2024 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced […]Read More
0 NASDAQ Companies - February 28, 2024Trupanion to Participate in the Raymond James 2024 Institutional Investors ConferenceSEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP) announced today that Margi Tooth, President, will present at the […]Read More
0 NASDAQ Companies - February 28, 2024Climb Global Solutions Reports Fourth Quarter and Full Year 2023 ResultsQ4 2023 Net Sales, Net Income, Adjusted EBITDA and EPS Increase to Record Levels FY 2023 Net Sales Increased 16% to […]Read More
0 NASDAQ Companies - February 28, 2024Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsAnticipate 2024 Product Revenue Growth of at Least 10% vs. 2023 Excluding Enzyme Sales Related to PAXLOVID™ Recently Announced Debt […]Read More
0 NASDAQ Companies - February 28, 2024MKS Instruments Receives 2023 Outstanding Service Award from MFLEXANDOVER, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (Nasdaq: MKSI), a global provider of technologies that transform […]Read More
0 NASDAQ Companies - February 28, 2024Arcutis and Sato Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in JapanArcutis to receive a $25 million upfront payment, and is eligible to receive potential development and commercial milestone payments (totaling […]Read More
0 NASDAQ Companies - February 28, 2024Energem Corp. Announces Shareholder Approval of Business Combination with Graphjet Technology Sdn. Bhd.~ Shareholders of Energem Corp. Approve Business Combinationon February 28, 2024 ~ ~ Upon Closing, the Combined Company is Expected […]Read More